Tiziana Life Sciences (NASDAQ:TLSA) Trading 9.3% Higher

Tiziana Life Sciences Ltd (NASDAQ:TLSAGet Free Report) shares shot up 9.3% during mid-day trading on Thursday . The company traded as high as $0.79 and last traded at $0.79. 162,059 shares were traded during trading, an increase of 0% from the average session volume of 161,977 shares. The stock had previously closed at $0.72.

Tiziana Life Sciences Price Performance

The business has a 50 day simple moving average of $0.77 and a 200 day simple moving average of $0.61.

Tiziana Life Sciences Company Profile

(Get Free Report)

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.

Featured Articles

Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.